Carter Bankshares Inc has a consensus price target of $19.3 based on the ratings of 5 analysts. The high is $22 issued by Hovde Group on October 2, 2024. The low is $16 issued by Raymond James on July 7, 2022. The 3 most-recent analyst ratings were released by Hovde Group, Raymond James, and Raymond James on October 2, 2024, August 29, 2024, and May 1, 2023, respectively. With an average price target of $20 between Hovde Group, Raymond James, and Raymond James, there's an implied 6.44% upside for Carter Bankshares Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Carter Bankshares (NASDAQ:CARE) was reported by Hovde Group on October 2, 2024. The analyst firm set a price target for $22.00 expecting CARE to rise to within 12 months (a possible 17.08% upside). 2 analyst firms have reported ratings in the last year.
The latest analyst rating for Carter Bankshares (NASDAQ:CARE) was provided by Hovde Group, and Carter Bankshares initiated their outperform rating.
The last upgrade for Carter Bankshares Inc happened on May 1, 2023 when Raymond James raised their price target to $17. Raymond James previously had a market perform for Carter Bankshares Inc.
The last downgrade for Carter Bankshares Inc happened on October 6, 2022 when DA Davidson changed their price target from $17.5 to $18.5 for Carter Bankshares Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter Bankshares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter Bankshares was filed on October 2, 2024 so you should expect the next rating to be made available sometime around October 2, 2025.
While ratings are subjective and will change, the latest Carter Bankshares (CARE) rating was a initiated with a price target of $0.00 to $22.00. The current price Carter Bankshares (CARE) is trading at is $18.79, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.